These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32329915)

  • 1. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection.
    van Damme C; Berlingin E; Saussez S; Accaputo O
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e300-e301. PubMed ID: 32329915
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 infection presenting as a febrile rash.
    Amatore F; Macagno N; Mailhe M; Demarez B; Gaudy-Marqueste C; Grob JJ; Raoult D; Brouqui P; Richard MA
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e304-e306. PubMed ID: 32330336
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-Coronavirus-2 and acute urticaria.
    Falkenhain-López D; Sánchez-Velázquez A; López-Valle A; Ortiz-Frutos FJ
    Int J Dermatol; 2020 Jul; 59(7):867-868. PubMed ID: 32441802
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous lesions in a patient with COVID-19: are they related?
    Ahouach B; Harent S; Ullmer A; Martres P; Bégon E; Blum L; Tess O; Bachmeyer C
    Br J Dermatol; 2020 Aug; 183(2):e31. PubMed ID: 32353170
    [No Abstract]   [Full Text] [Related]  

  • 5. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.
    Altayeb A; Cordaro A; Caesar J; Vyas J; Ingram J
    Int J Dermatol; 2020 Dec; 59(12):1541-1542. PubMed ID: 33084036
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of COVID-19 pneumonia presenting with acute urticaria.
    Naziroğlu T; Sözen S; Özkan P; Şeker S; Aksu K
    Dermatol Ther; 2020 Jul; 33(4):e13575. PubMed ID: 32401411
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis.
    Vischini G; D'Alonzo S; Grandaliano G; D'Ascenzo FM
    Kidney Int; 2020 Jul; 98(1):237-238. PubMed ID: 32413379
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.
    Caroppo F; Biolo G; Belloni Fortina A
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e368. PubMed ID: 32386431
    [No Abstract]   [Full Text] [Related]  

  • 9. Minor aphthae associated with SARS-CoV-2 infection.
    Dominguez-Santas M; Diaz-Guimaraens B; Fernandez-Nieto D; Jimenez-Cauhe J; Ortega-Quijano D; Suarez-Valle A
    Int J Dermatol; 2020 Aug; 59(8):1022-1023. PubMed ID: 32557570
    [No Abstract]   [Full Text] [Related]  

  • 10. Smell and taste dysfunction in patients with COVID-19.
    Xydakis MS; Dehgani-Mobaraki P; Holbrook EH; Geisthoff UW; Bauer C; Hautefort C; Herman P; Manley GT; Lyon DM; Hopkins C
    Lancet Infect Dis; 2020 Sep; 20(9):1015-1016. PubMed ID: 32304629
    [No Abstract]   [Full Text] [Related]  

  • 11. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
    Piccolo V; Neri I; Manunza F; Mazzatenta C; Bassi A
    Int J Dermatol; 2020 Aug; 59(8):1026-1027. PubMed ID: 32496583
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphic cutaneous manifestations of COVID-19 infection in a single viral host.
    Patel N; Kho J; Smith KE; Ahmed A; Van den Abbeele K; Mandal AKJ; Missouris CG
    Int J Dermatol; 2020 Sep; 59(9):1149-1150. PubMed ID: 32686096
    [No Abstract]   [Full Text] [Related]  

  • 13. Seborrheic dermatitis in COVID-19: a case report.
    Alpalhão M; Gaibino N; Filipe P
    Int J Dermatol; 2020 Dec; 59(12):1543-1544. PubMed ID: 33095515
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics of dermatologic manifestations of COVID-19 infection: case series of 15 patients, review of literature, and proposed etiological classification.
    Potekaev NN; Zhukova OV; Protsenko DN; Demina OM; Khlystova EA; Bogin V
    Int J Dermatol; 2020 Aug; 59(8):1000-1009. PubMed ID: 32621287
    [No Abstract]   [Full Text] [Related]  

  • 15. Urticarial eruption in coronavirus disease 2019 infection: a case report in Tangerang, Indonesia.
    Gunawan C; Angela A; Widysanto A
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e372-e373. PubMed ID: 32386435
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital.
    Fujiwara Y; Sato Y; Wang X; Oikado K; Sato Y; Fukuda N; Enokida T; Takeda K; Ohkushi D; Hayama B; Egi Y; Tokai Y; Yamada Y; Nakajima Y; Kubota M; Haruki S; Shimizu T; Uchida Y; Utsugi K; Ito Y; Ohno S; Takahashi S; Tsuchida T;
    Cancer Cell; 2020 Nov; 38(5):609-610. PubMed ID: 33064994
    [No Abstract]   [Full Text] [Related]  

  • 17. Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic.
    Kim YJ; Park H; Choi YY; Kim YK; Yoon Y; Kim KR; Choi EH
    J Korean Med Sci; 2020 Jun; 35(22):e204. PubMed ID: 32508068
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous manifestation of COVID-19 reporting from Middle-Eastern countries: A point of view!
    Abdelmaksoud A; Shakshouk H; Goldust M; Dursun R; Temiz SA; Vestita M
    Int J Dermatol; 2020 Dec; 59(12):1547-1548. PubMed ID: 33099771
    [No Abstract]   [Full Text] [Related]  

  • 19. Utility of hyposmia and hypogeusia for the diagnosis of COVID-19.
    Bénézit F; Le Turnier P; Declerck C; Paillé C; Revest M; Dubée V; Tattevin P;
    Lancet Infect Dis; 2020 Sep; 20(9):1014-1015. PubMed ID: 32304632
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy.
    De Giorgi V; Recalcati S; Jia Z; Chong W; Ding R; Deng Y; Scarfi F; Venturi F; Trane L; Gori A; Silvestri F; Gao XH; Lotti T
    J Am Acad Dermatol; 2020 Aug; 83(2):674-675. PubMed ID: 32442696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.